Treatment management of small renal masses in the 21st century: a paradigm shift.
about
Small renal masses in the elderly: Contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategiesManagement of inferior vena cava tumor thrombus in locally advanced renal cell carcinomaSurvival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma.Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.Clinical predictors of the estimated glomerular filtration rate 1 year after radical nephrectomy in Japanese patients.Contemporary incidence and mortality rates of kidney cancer in the United States.Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma.Ultrasound-guided radiofrequency ablation for cT1a renal masses in poor surgical candidates: mid-term, single-center outcomesSurvival after partial and radical nephrectomy for high-risk disease: A propensity-matched comparison.Survival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical management.Evaluation of robotic and laparoscopic partial nephrectomy for small renal tumours (T1a).Zero-ischemia minimally invasive partial nephrectomy.Trends in surgical management of T1 renal cell carcinoma.Less overdiagnosis of kidney cancer? an age-period-cohort analysis of incidence trends in 16 populations worldwide.Increased use of partial nephrectomy to treat high-risk disease.Trends in the surgical management of stage 1 renal cell carcinoma: findings from a population-based study.Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass.Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma.Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit.Is there a role for neoadjuvant targeted therapy to downsize primary tumors for organ sparing strategies in renal cell carcinoma?Surgeon-specific factors affecting treatment decisions among Canadian urologists in the management of pT1a renal tumours.Kidney function following partial or radical nephrectomy for renal cell carcinoma: a population-based study.Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities.Sociodemographic disparities in the treatment of small renal masses.Patient and provider experiences with active surveillance: A scoping review.Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes.Kidney cancer: Recurrence in renal cell carcinoma: the work is not done.Treatment approaches to small renal masses in patients of advanced age (≥75 years).
P2860
Q26738778-9F4F4E08-2C28-4B0E-A932-89A5D0FF589CQ26786534-61B8C183-C835-413A-B32B-83DB3575D48EQ33683920-8E0D3E8B-0AE0-422B-A3E7-0E9DEC47B484Q33774233-56481CB6-8F7A-4874-9BAF-D3D3B7CCE4BDQ33863080-2D71E23F-57B3-4E05-BB84-CEFC1823469DQ34062429-688CC2D9-CADE-4F0E-9DA6-E0F446C91F7BQ35875942-A0B81E46-8F70-4ED1-A3DB-3649EC4A3659Q37168003-C0483894-8DCF-4976-B9DA-94698463A8DCQ37265994-134E2F6A-C71E-4346-B059-0DC31788BED3Q37482444-C7999CD8-6A71-41E2-979D-F4CCCFA0BF82Q38088393-38C677D2-9888-422F-BD99-49F90F21631AQ38124767-4A48BE58-B08D-47DA-BAE1-72774EEC3F67Q38177710-7BF2CF93-5106-40F6-9F3F-9B23622088EAQ38400821-33B255E1-A990-4821-8EF0-401C45800D5FQ38573517-703C7D4E-6F27-4403-ABCF-E12A9FF4B588Q38815249-05577E9F-5F12-4204-B3BE-E686D8FDFA0DQ39406209-3601B8BD-28EC-4E31-B5F5-29DFEA456A10Q39417073-C7EE2015-BFBC-444C-82A7-5DEEF81176E7Q41260877-FAA4077E-252F-4FD7-948D-E1D8B1F74EA3Q41886782-F2E40DCF-6AD0-4E5E-ADCE-32272AA89EC8Q41973116-C0525DFA-03CA-4C27-A21C-713FB3898FA7Q43995082-6526A043-AC05-4F3B-BD0A-0DB6E0DA6653Q44087258-4F43CEAB-8B44-462D-A8A5-80770E06550BQ46942661-E95CD930-71C3-4C66-9CBD-7AA10820B7DBQ48105242-743B3C64-46B0-480A-AC8A-F1E391E65D30Q52981878-49D75549-481E-4AA6-B5BF-265E42F2D270Q54760339-C7A71A55-E20F-47B9-A82C-6B6B7E7E8033Q55439104-B21F3063-1DF0-4E5B-BEE7-515D6E605904
P2860
Treatment management of small renal masses in the 21st century: a paradigm shift.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Treatment management of small renal masses in the 21st century: a paradigm shift.
@en
Treatment management of small renal masses in the 21st century: a paradigm shift.
@nl
type
label
Treatment management of small renal masses in the 21st century: a paradigm shift.
@en
Treatment management of small renal masses in the 21st century: a paradigm shift.
@nl
prefLabel
Treatment management of small renal masses in the 21st century: a paradigm shift.
@en
Treatment management of small renal masses in the 21st century: a paradigm shift.
@nl
P2093
P2860
P50
P1476
Treatment management of small renal masses in the 21st century: a paradigm shift
@en
P2093
Francesco Montorsi
Maxine Sun
Paul Perrotte
Pierre I Karakiewicz
Quoc-Dien Trinh
Rodolphe Thuret
Shahrokh F Shariat
P2860
P2888
P304
P356
10.1245/S10434-012-2247-0
P577
2012-02-10T00:00:00Z
P6179
1005107920